MRKNYSEPharmaceutical PreparationsFiscal year ends December 31

Merck & Co., Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$143.63−2.32 (-1.59%)

Close on Oct 19, 2026

Market cap: $354.77B
P/E (TTM): 114.9
Dividend yield: 2.28%

Merck & Co., Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-31
Revenue	65,011	64,168	60,115	59,283	48,704	41,518	39,121	42,294	40,122	39,807	39,498	42,237	44,033	47,267	48,047	45,987	27,428	23,850	24,198
Cost of Revenue	16,382	15,193	16,126	17,411	13,626	13,618	12,016	13,509	12,912	14,030	14,934	16,768	16,954	16,446	16,871	18,396	9,019	5,583	6,141
Gross Profit	48,629	48,975	43,989	41,872	35,078	27,900	27,105	28,785	27,210	25,777	24,564	25,469	27,079	30,821	31,176	27,591	18,409	18,267	18,057
Research & Development	15,789	17,938	30,531	13,548	12,245	13,397	9,724	9,752	10,339	10,261	6,704	7,180	7,503	8,168	8,467	11,111	5,845	4,805	4,883
Selling, General & Admin	10,733	10,816	10,504	10,042	9,634	8,955	9,455	10,102	10,074	10,017	10,313	11,606	11,911	12,776	13,733	13,125	8,543	7,377	7,557
Advertising Expenses	2,300	2,400	2,300	2,200	2,000	1,800	1,900	2,100	2,200	2,100	2,100	2,300	2,500	2,800	3,100	–	–	–	–
Interest Expense	1,357	1,271	1,146	962	806	831	893	772	754	693	672	732	801	714	695	715	460	251	–
Interest & Investment Income	343	415	365	157	36	59	274	343	385	328	289	266	264	232	145	83	210	631	–
Income from Equity Investments	–	–	–	–	–	–	–	–	42	86	205	257	404	642	610	587	2,235	2,561	2,977
Other Non-Operating Income	-151	24	-466	-1,501	1,341	890	-129	402	500	-189	-1,527	11,613	-411	-1,116	-946	-1,304	10,668	2,318	75
Merger & Restructuring Charges	889	309	599	337	661	575	626	632	776	651	619	1,013	1,709	664	1,306	985	1,634	1,033	327
Asset Impairment Charges	–	–	–	1,749	302	1,718	1,040	296	646	3,948	162	1,222	765	200	705	2,441	–	–	–
Gain (Loss) on Investments	368	14	340	-1,419	1,940	1,338	170	324	352	43	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	–	–	–	0	0	11,209	0	0	127	–	–	–	–
Legal Settlements	–	–	–	–	–	–	–	0	0	-625	0	0	0	-493	-500	-950	0	0	-4,850
Pretax Income	21,067	19,936	1,889	16,444	13,879	5,863	7,171	8,701	6,521	4,659	5,401	17,283	5,545	8,739	7,334	1,653	15,290	–	–
Income Tax Expense	2,804	2,803	1,512	1,918	1,521	1,340	1,565	2,508	4,103	718	942	5,349	1,028	2,440	942	671	2,268	1,999	95
Income from Continuing Operations	–	–	365	14,519	12,345	4,519	5,690	–	–	–	–	–	–	–	–	–	–	–	–
Income from Discontinued Operations	–	–	0	0	707	2,559	4,171	–	–	–	–	–	–	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	18,263	17,133	377	14,526	–	7,082	9,777	6,193	2,418	3,941	4,459	11,934	4,517	6,299	6,392	982	13,022	7,932	3,397
Minority Interest in Earnings	9.00	16	12	7.00	16	15	-66	-27	24	21	17	14	113	131	120	121	123	124	121
Net Income	18,254	17,117	365	14,519	13,049	7,067	9,843	6,220	2,394	3,920	4,442	11,920	4,404	6,168	6,272	861	12,899	7,808	3,275
Net Income to Common	18,254	17,117	365	14,519	13,049	7,067	9,843	–	–	–	–	11,920	4,404	6,165	6,257	859	12,853	7,788	3,275
EPS (Basic)(per share)	7.30	6.76	0.14	5.73	5.16	2.79	3.84	2.34	0.88	1.42	1.58	4.12	1.49	2.03	2.04	0.28	5.67	3.65	1.51
EPS (Diluted)(per share)	7.28	6.74	0.14	5.71	5.14	2.78	3.81	2.32	0.87	1.41	1.56	4.07	1.47	2.00	2.02	0.28	5.65	3.63	1.49
Shares Outstanding (Basic, Weighted)(shares)	2,502	2,532	2,537	2,532	2,530	2,530	2,565	2,664	2,730	2,766	2,816	2,894	2,963	3,041	3,071	0.00	2,268	2,136	–
Shares Outstanding (Diluted, Weighted)(shares)	2,507	2,541	2,547	2,542	2,538	2,541	2,580	2,679	2,748	2,787	2,841	2,928	2,996	3,076	3,094	0.00	2,273	2,143	–
Dividend per Share(per share)	3.28	3.12	2.96	2.80	2.64	2.48	2.26	1.99	1.89	1.85	1.81	1.77	1.73	1.69	1.56	1.52	1.52	1.52	1.52

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 73.0%
Operating margin: –
Net margin: 4.8%
Return on equity, FY2025: 36.9%

Financial strength

Current ratio: 1.32
Debt to equity: 1.29
Debt to assets: 41.5%
Cash to current liabilities: 24.7%

Valuation

P/E ratio: 114.9
Price to sales: 5.33
Price to book: 8.46
Dividend yield: 2.28%